BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24627589)

  • 1. Evaluation of renal function in patients with cirrhosis: where are we now?
    Rognant N; Lemoine S
    World J Gastroenterol; 2014 Mar; 20(10):2533-41. PubMed ID: 24627589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calibration and precision of serum creatinine and plasma cystatin C measurement: impact on the estimation of glomerular filtration rate.
    Delanaye P; Cavalier E; Cristol JP; Delanghe JR
    J Nephrol; 2014 Oct; 27(5):467-75. PubMed ID: 24711159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chronic kidney disease epidemiology collaboration equation combining creatinine and cystatin C accurately assesses renal function in patients with cirrhosis.
    Krones E; Fickert P; Zitta S; Neunherz S; Artinger K; Reibnegger G; Durchschein F; Wagner D; Stojakovic T; Stadlbauer V; Fauler G; Stauber R; Zollner G; Kniepeiss D; Rosenkranz AR
    BMC Nephrol; 2015 Dec; 16():196. PubMed ID: 26627205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic Glomerular Filtration Rate Estimation Compared With Other Formulas for Evaluating Acute Kidney Injury Stage Early After Kidney Donation.
    Hekmat R; Eshraghi H; Esmailpour M; Hassankhani GG
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):104-109. PubMed ID: 28260446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystatin C and Sarcopenia Predict Acute on Chronic Liver Failure Development and Mortality in Patients on the Liver Transplant Waiting List.
    Mauro E; Crespo G; Martinez-Garmendia A; Gutierrez-Acevedo MN; Diaz JM; Saidman J; Bermudez C; Ortiz-Patron J; Garcia-Olveira L; Zalazar F; Narvaez A; Spina JC; Orta R; Savluk L; Piano S; Marciano S; Gadano A
    Transplantation; 2020 Jul; 104(7):e188-e198. PubMed ID: 32150034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretransplant renal function according to CKD-EPI cystatin C equation is a prognostic factor of death after liver transplantation.
    Uguen T; Jezequel C; Ropert M; Houssel-Debry P; Latournerie M; Lainé F; Deugnier Y; Vigneau C; Boudjema K; Guyader D; Bardou-Jacquet E
    Liver Int; 2016 Apr; 36(4):547-54. PubMed ID: 26502295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum cystatin C-based equation compared to serum creatinine-based equations for estimation of glomerular filtration rate in patients with chronic kidney disease.
    Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
    Clin Nephrol; 2008 Jul; 70(1):10-7. PubMed ID: 18793543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The discrepancy between serum creatinine and cystatin C can predict renal function after treatment for postrenal acute kidney injury: multicenter study and pooled data analysis.
    Matsuki M; Tanaka T; Maehana T; Kyoda Y; Ichihara K; Hashimoto K; Yanase M; Matsukawa M; Adachi H; Takahashi S; Masumori N
    Clin Exp Nephrol; 2017 Oct; 21(5):852-857. PubMed ID: 28258496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Cystatin C as an Indicator of Renal Function and Mortality in Liver Transplant Recipients.
    Allen AM; Kim WR; Larson JJ; Colby C; Therneau TM; Rule AD
    Transplantation; 2015 Jul; 99(7):1431-5. PubMed ID: 25654627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to evaluate renal function in stable cirrhotic patients.
    Aiello FI; Bajo M; Marti F; Musso CG
    Postgrad Med; 2017 Nov; 129(8):866-871. PubMed ID: 28787218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple cystatin C formula for estimation of glomerular filtration rate in overweight patients with diabetes mellitus type 2 and chronic kidney disease.
    Bevc S; Hojs R; Ekart R; Završnik M; Gorenjak M; Puklavec L
    Exp Diabetes Res; 2012; 2012():179849. PubMed ID: 23008697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating renal function in children: a new GFR-model based on serum cystatin C and body cell mass.
    Andersen TB
    Dan Med J; 2012 Jul; 59(7):B4486. PubMed ID: 22759853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of creatinine and cystatin formulae with
    Cholongitas E; Ioannidou M; Goulis I; Chalevas P; Ntogramatzi F; Athanasiadou Z; Notopoulos A; Alevroudis M; Sinakos E; Akriviadis E
    J Gastroenterol Hepatol; 2017 Jan; 32(1):191-198. PubMed ID: 27177318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis and assessment of renal function in patients with liver cirrhosis.
    Teneva BH
    Folia Med (Plovdiv); 2012; 54(4):5-13. PubMed ID: 23441464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of renal function, which and when?
    Wasung ME; Chawla LS; Madero M
    Clin Chim Acta; 2015 Jan; 438():350-7. PubMed ID: 25195004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum cystatin C level is a useful marker for the evaluation of renal function in patients with cirrhotic ascites and normal serum creatinine levels.
    Kim DJ; Kang HS; Choi HS; Cho HJ; Kim ES; Keum B; An H; Kim JH; Seo YS; Kim YS; Yim HJ; Jeen YT; Lee HS; Um SH; Kim CD; Ryu HS
    Korean J Hepatol; 2011 Jun; 17(2):130-8. PubMed ID: 21757984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis.
    Sato H; Kuroda T; Tanabe N; Ajiro J; Wada Y; Murakami S; Sakatsume M; Nakano M; Gejyo F
    Scand J Rheumatol; 2010; 39(1):33-7. PubMed ID: 20132068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cystatin C and creatinine-based glomerular filtration rate formulas with 51Cr-EDTA clearance in patients with cirrhosis.
    Xirouchakis E; Marelli L; Cholongitas E; Manousou P; Calvaruso V; Pleguezuelo M; Guerrini GP; Maimone S; Kerry A; Hajjawi M; Nair D; Thomas M; Patch D; Burroughs AK
    Clin J Am Soc Nephrol; 2011 Jan; 6(1):84-92. PubMed ID: 20829419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Estimation of glomerular filtration rate using cystatin C].
    Bargnoux AS; Barguil Y; Cavalier E; Cristol JP
    Ann Biol Clin (Paris); 2019 Aug; 77(4):375-380. PubMed ID: 31418698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.
    Flores-Blanco PJ; Manzano-Fernández S; Pérez-Calvo JI; Pastor-Pérez FJ; Ruiz-Ruiz FJ; Carrasco-Sánchez FJ; Morales-Rull JL; Pascual-Figal D; Galisteo-Almeda L; Januzzi JL
    Clin Cardiol; 2015 Feb; 38(2):106-13. PubMed ID: 25663560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.